CD8A and neoplasm: By using γδ T cell-derived extracellular vesicles (γδ TDE) loaded with miR-138, Li et al. (2019) showed that γδ TDE could directly inhibit OSCC tumor progression by up-regulating anti-tumor immunity through enhanced CD8 + T cells in pre-immunized immunocompetent C3H mice.